GlassScriptPhysician profile
Amber Wood
NPI 1528583747
$1,141.52
in general payments reported to CMS, 2019-2025
20 companies · $281 in 2025
The $281 reported for 2025 was more than what a typical Obstetrics & Gynecology (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $119 · 2022: $305 · 2023: $153 · 2024: $283 · 2025: $281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $718.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $717.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $231.61 | 2021-2025 | Slynd |
| Organon LLC | $126.20 | 2022-2025 | Nexplanon |
| Abbvie INC. | $122.51 | 2021-2023 | |
| Mylan Pharmaceuticals INC. | $89.58 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $88.29 | 2025 | |
| Shield Therapeutics INC | $68.20 | 2024 | |
| Millicent US INC | $54.98 | 2022-2023 | Femring, Intrarosa |
| Astellas Pharma US INC | $48.51 | 2025 | Veozah |
| Hologic Sales and Service, LLC | $47.82 | 2025 | Aptima |
| Biogen, INC. | $42.62 | 2024 | |
| Aspira Women'S Health INC | $35.03 | 2024 | Ova1 |
| Coopersurgical, INC. | $32.31 | 2021-2023 | Paragard T 380a |
| Agile Therapeutics, INC. | $28.49 | 2022-2023 | Twirla |
| Conmed Corporation | $22.20 | 2024 | Vcare, Airseal, Visiclear |
| Bayer Healthcare Pharmaceuticals INC. | $21.47 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $19.04 | 2025 | The Cologuard Plus Collection Kit |
| Ethicon US, LLC | $17.50 | 2022 | |
| Mayne Pharma Commercial LLC | $17.25 | 2022 | |
| Sumitomo Pharma America, INC. | $14.02 | 2023 | Myfembree |
| Evofem Biosciences, INC. | $13.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Wood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.